Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000558576 | SCV000650913 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002404520 | SCV002709203 | likely benign | Cardiovascular phenotype | 2022-04-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002497173 | SCV002808618 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26 | 2022-04-25 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003144347 | SCV003833200 | uncertain significance | not provided | 2021-08-28 | criteria provided, single submitter | clinical testing |